Noah Goodman insider trades

Open-market stock purchases and sales by Noah Goodman, Chief Business Officer at Kymera Therapeutics, Inc, from SEC Form 4 filings since Apr 8, 2025.

Recent trades

DateStockTradeValue
Jul 1, 2026KYMR Kymera Therapeutics, IncSold$387K
Jun 25, 2026KYMR Kymera Therapeutics, IncSold$298K
Jun 25, 2026KYMR Kymera Therapeutics, IncBought (not open market)—
Jun 22, 2026KYMR Kymera Therapeutics, IncSold$248K
Jun 22, 2026KYMR Kymera Therapeutics, IncBought (not open market)—
Apr 14, 2026KYMR Kymera Therapeutics, IncSold$121K
Apr 10, 2026KYMR Kymera Therapeutics, IncSold$175K
Apr 9, 2026KYMR Kymera Therapeutics, IncSold$268K
Apr 9, 2026KYMR Kymera Therapeutics, IncSold$233K
Apr 9, 2026KYMR Kymera Therapeutics, IncSold$223K
Apr 9, 2026KYMR Kymera Therapeutics, IncBought (not open market)—
Mar 2, 2026KYMR Kymera Therapeutics, IncBought (not open market)—
Mar 2, 2026KYMR Kymera Therapeutics, IncBought (not open market)—

Companies traded

  • KYMR Kymera Therapeutics, Inc: 8 sales, last Jul 1, 2026

Get free alerts when Noah Goodman files a new trade →